Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suicide attempt, impulsivity, and exposure to trauma in college students.
Lira SB, Vieira F, Cavalcanti DE, Souza-Marques B, Netto LR, Correia-Melo FS, Leal GC, Pereira JL, Santos LL, Guedes GM, Teles CA, Cardoso TA, Miranda-Scippa Â, Kapczinski F, Lacerda ALT, Koenen KC, Turecki G, Quarantini LC. Lira SB, et al. Among authors: leal gc. Braz J Psychiatry. 2022 May-Jun;44(3):279-288. doi: 10.1590/1516-4446-2021-2175. Braz J Psychiatry. 2022. PMID: 35262616 Free PMC article.
Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial.
Vieira F, Correia-Melo FS, Santos-Lima C, Souza-Marques B, Leal GC, Jesus-Nunes AP, Mello RP, Caliman-Fontes AT, Bandeira ID, Marback RF, Telles M, Argolo FC, Lins-Silva DH, Echegaray MVF, Beanes G, Araújo-de-Freitas L, Silva SS, Cardoso TA, Kapczinski F, Turecki G, Lacerda ALT, Quarantini LC. Vieira F, et al. Among authors: leal gc. Gen Hosp Psychiatry. 2021 Jan-Feb;68:97-99. doi: 10.1016/j.genhosppsych.2020.12.011. Epub 2020 Dec 20. Gen Hosp Psychiatry. 2021. PMID: 33376001 Clinical Trial. No abstract available.
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Caliman-Fontes AT, Leal GC, Correia-Melo FS, Paixão CS, Carvalho MS, Jesus-Nunes AP, Vieira F, Magnavita G, Bandeira ID, Mello RP, Beanes G, Silva SS, Echegaray M, Carvalho LP, Machado P, Sampaio AS, Cardoso TA, Kapczinski F, Lacerda ALT, Quarantini LC. Caliman-Fontes AT, et al. Among authors: leal gc. Trends Psychiatry Psychother. 2023;45:e20210298. doi: 10.47626/2237-6089-2021-0298. Epub 2023 Mar 7. Trends Psychiatry Psychother. 2023. PMID: 34904800 Free PMC article. Clinical Trial.
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Jesus-Nunes AP, Leal GC, Correia-Melo FS, Vieira F, Mello RP, Caliman-Fontes AT, Echegaray MVF, Marback RF, Guerreiro-Costa LNF, Souza-Marques B, Santos-Lima C, Souza LS, Bandeira ID, Kapczinski F, Lacerda ALT, Quarantini LC. Jesus-Nunes AP, et al. Among authors: leal gc. Hum Psychopharmacol. 2022 Jul;37(4):e2836. doi: 10.1002/hup.2836. Epub 2022 Feb 18. Hum Psychopharmacol. 2022. PMID: 35179810 Clinical Trial.
Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series.
Faria-Guimarães D, Vieira F, Souza-Marques B, Silva SS, Bandeira ID, Souza LS, Alves-Pereira R, Fontes M, Mello RP, Leal GC, Cardoso TA, Kapczinski F, Lacerda ALT, Sampaio AS, Quarantini LC. Faria-Guimarães D, et al. Among authors: leal gc. J Child Adolesc Psychopharmacol. 2022 Aug;32(6):366-367. doi: 10.1089/cap.2022.0013. Epub 2022 Jun 16. J Child Adolesc Psychopharmacol. 2022. PMID: 35708566 No abstract available.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
Correia-Melo FS, Leal GC, Carvalho MS, Jesus-Nunes AP, Ferreira CBN, Vieira F, Magnavita G, Vale LAS, Mello RP, Nakahira C, Argolo FC, Cardoso T, Souza CDS, Fontes ATC, Ferreira MB, Araújo-de-Freitas L, Tuena MA, Echegaray MVF, Cavalcanti DE, Lucchese AC, Bandeira ID, Telles M, Lima CS, Sampaio AS, Silva SS, Marback RF, Del-Porto JA, Abreu JN, Sarin LM, Paixão CS, Carvalho LP, Machado PRL, Turecki G, Lacerda ALT, Quarantini LC. Correia-Melo FS, et al. Among authors: leal gc. Medicine (Baltimore). 2018 Sep;97(38):e12414. doi: 10.1097/MD.0000000000012414. Medicine (Baltimore). 2018. PMID: 30235716 Free PMC article. Clinical Trial.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes AP, Mello RP, Magnavita G, Caliman-Fontes AT, Echegaray MVF, Bandeira ID, Silva SS, Cavalcanti DE, Araújo-de-Freitas L, Sarin LM, Tuena MA, Nakahira C, Sampaio AS, Del-Porto JA, Turecki G, Loo C, Lacerda ALT, Quarantini LC. Correia-Melo FS, et al. Among authors: leal gc. J Affect Disord. 2020 Mar 1;264:527-534. doi: 10.1016/j.jad.2019.11.086. Epub 2019 Nov 14. J Affect Disord. 2020. PMID: 31786030 Clinical Trial.
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial.
Mello RP, Echegaray MVF, Jesus-Nunes AP, Leal GC, Magnavita GM, Vieira F, Caliman-Fontes AT, Telles M, Guerreiro-Costa LNF, Souza-Marques B, Bandeira ID, Santos-Lima C, Marback RF, Correia-Melo FS, Lacerda ALT, Quarantini LC. Mello RP, et al. Among authors: leal gc. J Psychiatr Res. 2021 Jun;138:576-583. doi: 10.1016/j.jpsychires.2021.05.014. Epub 2021 May 8. J Psychiatr Res. 2021. PMID: 33991996 Clinical Trial.
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
Souza-Marques B, Telles M, Leal GC, Faria-Guimarães D, Correia-Melo FS, Jesus-Nunes AP, Vieira F, Souza L, Lins-Silva D, Mello RP, Guerreiro-Costa L, Bandeira ID, Lacerda ALT, Sampaio AS, Quarantini LC. Souza-Marques B, et al. Among authors: leal gc. J Clin Psychopharmacol. 2022 Jul-Aug 01;42(4):408-412. doi: 10.1097/JCP.0000000000001571. Epub 2022 Jun 21. J Clin Psychopharmacol. 2022. PMID: 35727083 Clinical Trial.
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
Beanes G, Caliman-Fontes AT, Souza-Marques B, Silva HDS, Leal GC, Carneiro BA, Guerreiro-Costa LNF, Figueiredo AV, Figueiredo CAV, Lacerda ALT, Costa RDS, Quarantini LC. Beanes G, et al. Among authors: leal gc. Clin Neuropharmacol. 2022 Nov-Dec 01;45(6):151-156. doi: 10.1097/WNF.0000000000000517. Epub 2022 Sep 11. Clin Neuropharmacol. 2022. PMID: 36093918 Clinical Trial.
43 results